The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Elevance Health is the larger company, worth $88.9B, about 8.5 times Oscar Health.
  • Elevance Health grew revenue faster over the last year (+1.4% vs -6.2%).
  • Oscar Health keeps more of each dollar of revenue as operating profit (2128.9% vs 2.7%).
  • Elevance Health's price assumes faster free cash flow growth: about 9% a year, against -4% for Oscar Health (reverse DCF).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureELVOSCR
Market cap$88.9B$10.4B
Share price$412.70$33.37
Revenue (last fiscal year)$199.1B$29M
Free cash flow (last fiscal year)$3.2B$1.1B
Revenue growth, last year+1.4%-6.2%
Revenue growth per year, last 5 fiscal years+9.5%+51.7%
Operating margin2.7%2128.9%
Net margin2.5%1861.9%
Return on equity11.1%26.8%
P/E (trailing)17.3x—
Price / free cash flow28.0x9.86x
EV / EBITDA12.6x9.58x
FCF growth the price implies9.4%-4.4%
Dividend yield1.6%—
Debt / equity1.81x4.47x
Fundamental gradeCC
Superinvestors holding it182
Insider purchases, last 12 months91

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Elevance Health

YearRevenueFree cash flowOp. margin
2021$138.6B$7.3B5.5%
2022$156.6B$7.2B5.3%
2023$171.3B$6.8B5.0%
2024$177.0B$4.6B4.4%
2025$199.1B$3.2B3.6%

Oscar Health

YearRevenueFree cash flowOp. margin
2021$5M-$208M-10094.2%
2022$65M$351M-908.5%
2023$21M-$298M-1103.4%
2024$21M$950M278.3%
2025$29M$1.1B-1386.2%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open ELV in Investingly

Questions

Which is bigger, Elevance Health or Oscar Health?

Elevance Health (ELV), at $88.9B against $10.4B.

Which grows faster, ELV or OSCR?

Elevance Health: revenue grew +1.4% over the last year, against -6.2%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.